![Důležité termíny](https://cdn.muni.cz/media/3633704/image_2.jpg?mode=crop¢er=0.5,0.5&rnd=133572412150000000&heightratio=0.5&width=278)
Informace o publikaci
Lenalidomide proved effective in multisystem Langerhans cell histiocytosis
Autoři | |
---|---|
Rok publikování | 2012 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Acta Oncologica |
Fakulta / Pracoviště MU | |
Citace | |
Doi | http://dx.doi.org/10.3109/0284186X.2011.631581 |
Obor | Onkologie a hematologie |
Klíčová slova | Langerhans cell histiocytosis; lenalidomide; PET/CT |
Popis | Langerhans cell histiocytosis (LCH) is a rare idiopathic disease with diverse clinical manifestations ranging from a single osteolytic lesion to generalized disease. Various treatment regimens have been proposed for the multisystem type, however, with inconsistent outcomes. Herein we are the first to report on a therapy effect of a lenalidomide-based regimen in a patient with repeatedly relapsed aggressive form of multisystem LCH. |
Související projekty: |
|